Also FWIW NEU is a totally different beast to other companies that recently entered and then existed in short timeframes; NEU has ongoing agreements in place for an FDA approved drug to improve the lives of families who have children suffering from Rhett’s syndrome, a terrible neurological disorder; this involves ongoing revenue and earnings for NEU.
NEU also has trials in place which hopefully will show positive P2 results in December; as well as communicating/hinting that eventually takeover offers will be considered.
Tick Tock, it’s only a matter of patience.
Share Price, page-6983
-
- There are more pages in this discussion • 4,886 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.76 |
Change
0.150(1.10%) |
Mkt cap ! $1.758B | |||
| Open | High | Low | Value | Volume |
| $13.60 | $14.00 | $13.51 | $5.043M | 365.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3816 | $13.73 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.78 | 2834 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |